C12N 2760/16252
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2760/16252 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 22 US grants and 31 published applications in this corpus.
Search patents in C12N- Granted patents
- 22
- Published applications
- 31
- Assignees
- 23
- Inventors
- 55
- Latest grant
- 16 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 0 | 3 |
| 2011 | 0 | 1 |
| 2012 | 1 | 3 |
| 2013 | 4 | 4 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 2 | 3 |
| 2017 | 2 | 3 |
| 2018 | 1 | 1 |
| 2019 | 3 | 1 |
| 2020 | 2 | 5 |
| 2021 | 1 | 0 |
| 2022 | 2 | 1 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Engineered influenza antigenic polypeptides and immunogenic compositions thereof16 Jul 2024US 12,037,364 B2Sanofi Pasteur Limited
- Engineered cells with decreased gene expression resulting in increased viral production23 May 2023US 11,655,471 B2University of Georgia Research Foundation, Inc.
- SO3 chromatography for use in a method for virus purification24 May 2022US 11,339,377 B2Bluesky Immunotherapies GmbH
- Engineered influenza antigenic polypeptides and immunogenic compositions thereof10 May 2022US 11,325,947 B2Sanofi Pasteur Limited
- Generation of infectious influenza viruses from virus-like particles23 Nov 2021US 11,180,737 B2Wisconsin Alumni Research Foundation (WARF)
- Modified influenza b hemagglutinin polypeptides and nucleic acids and uses thereof20 Mar 2025US 2025/0090650 A1Sanofi
- Engineered influenza antigenic polypeptides and immunogenic compositions thereof4 Aug 2022US 2022/0242918 A1Sanofi Pasteur Limited
- So3 chromatography for use in a method for virus purification22 Oct 2020US 2020/0332264 A1BIA Separations d.o.o.
- Generation of infectious influenza viruses from virus-like particles20 Aug 2020US 2020/0263142 A1Wisconsin Alumni Research Foundation (WARF)
- Engineered influenza antigenic polypeptides and immunogenic compositions thereof16 Jul 2020US 2020/0223892 A1Sanofi Pasteur Limited
Most cited
By later US patents
- Multi plasmid system for the production of influenza virus34US 8,093,033 B2MedImmune, LLC · 2012
- Method of purifying influenza virus and removing MDCK cell DNA contaminants32US 8,357,376 B2Memimmune, LLC · 2013
- Multi plasmids system for the production of influenza virus31US 8,409,843 B2MedImmune, LLC · 2013
- Generation of infectious influenza viruses from virus-like particles18US 10,494,613 B2Wisconsin Alumni Research Foundation (WARF) · 2019
- Generation of infectious influenza viruses from virus-like particles16US 11,180,737 B2Wisconsin Alumni Research Foundation (WARF) · 2021